18Mar
Impact of COVID-19 on US and EU Merger Review and Enforcement
Last week, in response to the outbreak of the Coronavirus disease (COVID19), the antitrust agencies in the United States and European Union issued policies that will affect, and may delay, merger filings and reviews. ...
By:
White & Case LLP
Related
I’m a long-suffering fan of the Mets and over the past two years, I’ve had to deal with the underw...
Read More >
This article covers cases from Southwestern Reporter (Third) volumes 560 through 580 and federal cas...
Read More >
On 1 July 2019 China's antitrust agency, the State Administration for Market Regulation (SAMR), made...
Read More >
In yet another end-of-2019 decision overruling significant NLRA precedent, the Board reverted to the...
Read More >
As an alternative to termination, employers faced with employee drug or alcohol policy violations so...
Read More >
The global outbreak of the novel coronavirus COVID-19 is having profound implications for businesses...
Read More >